OncoTherics is delighted to announce the appointment of Dr Thomas Morris as the company’s new Director and Chief Medical Officer.
Dr Morris has worked in drug development for over 20 years with much of this time specialising in oncology. He joins OncoTherics after a long and successful career at AstraZeneca where he has held a number of senior global R&D roles. Most recently these include Senior Medical Director, Executive Director Clinical Programs and Medical Science Director.
Dr Morris has overseen the clinical development of several global drug programs, interacting with academic groups and regulatory agencies worldwide. He brings a considerable wealth of experience to OncoTherics and will lead the company’s clinical trial programme.